Aberdeen Group Portfolio holdings
Aberdeen Group is a British wealth and investment company, created in 2017 when Standard Life merged with Aberdeen Asset Management. In 2018 it agreed to sell the Standard Life insurance business to Phoenix Group, shifting the company from insurance toward asset management. After selling the Standard Life name to Phoenix Group in 2021 it rebranded as abrdn, a vowel-free name that drew criticism, and in 2025 it went back to Aberdeen. Among its businesses is Interactive Investor, a British retail investing service that runs on subscriptions, which it bought in 2022.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$319M |
| 2 |
Amazon
AMZN
|
+$165M |
| 3 |
Microsoft
MSFT
|
+$110M |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$92.7M |
| 5 |
UnitedHealth
UNH
|
+$69.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$182M |
| 2 |
RTX Corp
RTX
|
+$97.9M |
| 3 |
Marvell Technology
MRVL
|
+$81.2M |
| 4 |
GE Vernova
GEV
|
+$80.7M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$73.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.75% |
| 2 | Healthcare | 12.68% |
| 3 | Consumer Discretionary | 10.96% |
| 4 | Communication Services | 10.76% |
| 5 | Financials | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
426
Supernus Pharmaceuticals
SUPN
$2.44B
| $21.1M | 0.03% |
453,206
+177,645
| +64% | +$8.53M |
2025 Q4
2 quarters
|
|
427
StoneX
SNEX
$6.37B
| $21M | 0.03% |
266,352
-117,687
| -31% | -$8.83M |
2025 Q3
3 quarters
|
|
428
Quaker Houghton
KWR
$2.6B
| $20.9M | 0.03% |
131,863
+27,000
| +26% | +$3.79M |
2026 Q1
1 quarter
|
|
429
PJT Partners
PJT
$3.83B
| $20.9M | 0.03% |
138,593
+7,203
| +5% | +$1.11M |
2020 Q3
23 quarters
|
|
430
IDEAYA Biosciences
IDYA
$3.08B
| $20.9M | 0.03% |
560,934
+15,303
| +3% | +$468K |
2024 Q3
7 quarters
|
|
431
Synchrony
SYF
$24.5B
| $20.9M | 0.03% |
274,762
+11,521
| +4% | +$846K |
2017 Q3
35 quarters
|
|
432
Hershey
HSY
$33.3B
| $20.9M | 0.03% |
118,978
+968
| +0.8% | +$183K |
2017 Q3
35 quarters
|
|
433
Verisk Analytics
VRSK
$25.5B
| $20.8M | 0.03% |
116,134
+8,637
| +8% | +$1.52M |
2017 Q3
35 quarters
|
|
434
Halliburton
HAL
$29.9B
| $20.8M | 0.03% |
612,548
+80,382
| +15% | +$3.14M |
2017 Q3
35 quarters
|
|
435
Enpro
NPO
$5.75B
| $20.7M | 0.03% |
54,981
-30,451
| -36% | -$9.46M |
2021 Q4
18 quarters
|
|
436
Skyward Specialty Insurance
SKWD
$2.62B
| $20.6M | 0.03% |
352,907
+58,842
| +20% | +$2.78M |
2025 Q2
4 quarters
|
|
437
Arrowhead Research
ARWR
$8.46B
| $20.5M | 0.03% |
251,968
-112,004
| -31% | -$8.27M |
2024 Q2
8 quarters
|
|
438
HP
HPQ
$26B
| $20.5M | 0.03% |
933,595
-133,405
| -13% | -$2.95M |
2017 Q3
35 quarters
|
|
439
Labcorp
LH
$29.3B
| $20.4M | 0.03% |
72,936
+2,162
| +3% | +$568K |
2017 Q3
35 quarters
|
|
440
Cincinnati Financial
CINF
$27.8B
| $20.4M | 0.03% |
110,143
+7,391
| +7% | +$1.23M |
2017 Q3
35 quarters
|
|
441
Huntington Bancshares
HBAN
$31.8B
| $20.3M | 0.03% |
1,145,819
-218,896
| -16% | -$3.61M |
2017 Q3
35 quarters
|
|
442
Fiserv Inc
FISV
$26.6B
| $20.2M | 0.03% |
412,446
-1,051
| -0.3% | -$58.7K |
2017 Q3
35 quarters
|
|
443
Mine Safety
MSA
$6.89B
| $20.1M | 0.03% |
115,417
-39,158
| -25% | -$6.56M |
2023 Q2
12 quarters
|
|
444
Jazz Pharmaceuticals
JAZZ
$14B
| $20.1M | 0.03% |
83,606
-30,522
| -27% | -$6.69M |
2025 Q3
3 quarters
|
|
445
Raymond James Financial
RJF
$30.2B
| $20.1M | 0.03% |
132,480
+19,294
| +17% | +$2.93M |
2017 Q3
35 quarters
|
|
446
Sanofi
SNY
$106B
| $20.1M | 0.03% |
471,254
+13,333
| +3% | +$596K |
2023 Q4
10 quarters
|
|
447
Arcus Biosciences
RCUS
$2.32B
| $20.1M | 0.03% |
650,712
-119,075
| -15% | -$2.94M |
2025 Q3
3 quarters
|
|
448
Illumina
ILMN
$35.6B
| $19.9M | 0.03% |
113,119
-4,257
| -4% | -$623K |
2017 Q3
35 quarters
|
|
449
Cognizant
CTSH
$29.1B
| $19.7M | 0.03% |
509,478
+48,208
| +10% | +$2.54M |
2017 Q3
35 quarters
|
|
450
Adaptive Biotechnologies
ADPT
$4.25B
| $19.7M | 0.03% |
918,998
-151,629
| -14% | -$2.32M |
2023 Q4
10 quarters
|
|
Similar funds
Aberdeen Group's Q2 2026 Portfolio in Review
As of Q2 2026, Aberdeen Group held 978 positions worth $71.2B, up 15% from $61.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Aberdeen Group's Q2 2026 filing shows 47 new, 453 increased, 412 reduced and 44 closed positions. Its largest new stake was Honeywell Aerospace: 420,093 shares worth $92.9M. The largest sale was Honeywell, an estimated $182M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Aberdeen Group's largest Q2 2026 buy was Honeywell Aerospace: 420,093 shares worth $92.9M.
- Aberdeen Group added most to Tesla in Q2 2026, an estimated $319M increase.
- Aberdeen Group's biggest Q2 2026 reduction was RTX Corp, cutting an estimated $97.9M.
- Aberdeen Group fully exited Honeywell in Q2 2026, selling an estimated $182M.
- Aberdeen Group's ten largest holdings make up 37% of its $71.2B portfolio in Q2 2026.
- Aberdeen Group opened 47 new positions and closed 44 in Q2 2026.
- Aberdeen Group's portfolio value rose 15% quarter-over-quarter to $71.2B.
Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.